[{"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-001", "question": "A 65-year-old male with ARDS is deeply sedated and paralyzed on volume-control ventilation. Paralysis is paused for a 'sedation holiday.' The ventilator waveform display subsequently shows a controlled breath delivered by the machine, followed immediately by a deflection in the flow waveform suggesting patient effort, which then triggers a second, stacked breath. Esophageal manometry reveals that the diaphragm electrical activity (EAdi) and negative esophageal pressure swing onset occur *after* the initiation of the first machine-delivered breath. What is the specific dyssynchrony described?", "options": ["Double triggering", "Reverse triggering", "Ineffective triggering", "Autocycling", "Flow starvation"], "answer": "B", "answer_index": 1, "explanation": "This is reverse triggering (entrainment). Unlike double triggering (where a sustained patient effort triggers two breaths), reverse triggering is a reflex where the mechanical inflation of the lung stretches the diaphragm, inducing a muscle contraction *after* the breath has started. This contraction can then trigger a second breath (breath stacking). The key distinction is the timing of the patient's effort relative to the machine cycle.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The scenario describes a situation where the ventilator delivers a controlled breath, and then the patient's diaphragm (indicated by EAdi and esophageal pressure) attempts to initiate a breath *after* the machine breath has already started. This patient effort, occurring after the machine breath, then triggers a second, stacked breath from the ventilator.\n\nLet's analyze the options:\n\n*   **A. Double triggering:** This occurs when the patient's inspiratory effort is so strong or prolonged that it triggers a second breath from the ventilator before the first breath is complete. While there is a stacked breath, the timing of the patient effort is key here.\n\n*   **B. Reverse triggering:** This is a form of patient-ventilator asynchrony where the patient's spontaneous inspiratory effort triggers a ventilator breath, but this ventilator breath then *causes* a diaphragmatic contraction, leading to a stacked breath. The key here is that the *ventilator breath initiates the patient effort*. The question states that EAdi and negative esophageal pressure onset occur *after* the initiation of the first machine-delivered breath. This aligns with reverse triggering, where the machine breath might be causing the patient's diaphragm to fire, leading to the stacked breath.\n\n*   **C. Ineffective triggering:** This occurs when the patient makes an inspiratory effort, but the ventilator fails to detect it and deliver a breath. This is not happening here, as the patient effort is triggering a second breath.\n\n*   **D. Autocycling:** This is when the ventilator delivers a breath without any patient effort. This is not the primary issue, as patient effort is involved in triggering the second breath.\n\n*   **E. Flow starvation:** This occurs when the patient's demand for flow exceeds the ventilator's ability to deliver it, leading to a concave flow waveform. This is not described in the scenario.\n\nThe crucial piece of information is that the patient's diaphragmatic electrical activity (EAdi) and negative esophageal pressure swing onset occur *after* the initiation of the first machine-delivered breath. This suggests that the machine breath itself is somehow stimulating the patient's diaphragm to contract, leading to the subsequent effort and the stacked breath. This is the hallmark of reverse triggering.\n\nThe final answer is $\\boxed{B}$."}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-002", "question": "A 72-year-old male presents with macrocytic anemia, intermittent fevers, and relapsing polychondritis resistant to standard immunosuppression. Bone marrow biopsy reveals vacuoles in myeloid and erythroid precursor cells. Cytogenetics are normal. Which of the following genetic mutations is most likely responsible for this clinical syndrome?", "options": ["JAK2 V617F", "UBA1", "SF3B1", "TET2", "MYD88"], "answer": "B", "answer_index": 1, "explanation": "The patient has VEXAS syndrome (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic), a recently described disorder caused by somatic mutations in the UBA1 gene. It typically affects older men and presents with treatment-refractory inflammatory symptoms (chondritis, vasculitis) and hematologic abnormalities (macrocytic anemia, vacuoles in marrow precursors).", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient presents with a constellation of symptoms and findings suggestive of a myelodysplastic syndrome (MDS) with specific features. Macrocytic anemia, intermittent fevers, and relapsing polychondritis resistant to standard immunosuppression are key clues. The presence of vacuoles in myeloid and erythroid precursor cells on bone marrow biopsy is a hallmark finding.\n\nLet's analyze the options:\n\nA. JAK2 V617F is commonly associated with myeloproliferative neoplasms (MPNs) like polycythemia vera, essential thrombocythemia, and primary myelofibrosis. While macrocytic anemia can occur in some MPNs, the specific combination of relapsing polychondritis and vacuolated precursors is not typical.\n\nB. UBA1 mutations are strongly associated with X-linked dyskeratosis congenita and also with a subset of patients with VEXAS syndrome (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic). VEXAS syndrome is characterized by relapsing polychondritis, recurrent fevers, and a distinctive vacuolated myeloid and erythroid precursor morphology in the bone marrow, often with macrocytic anemia. This fits the clinical presentation very well.\n\nC. SF3B1 mutations are frequently found in patients with MDS with ring sideroblasts (MDS-RS), particularly the subtype with macrocytosis. While macrocytic anemia is present, SF3B1 mutations are not typically associated with relapsing polychondritis or the specific vacuolated precursor morphology described.\n\nD. TET2 mutations are common in various myeloid malignancies, including MDS and MPNs. They can contribute to the development of macrocytic anemia. However, TET2 mutations are not specifically linked to relapsing polychondritis or the characteristic vacuolated precursors seen in this case.\n\nE. MYD88 mutations are primarily associated with lymphoplasmacytic lymphoma (Waldenstr√∂m's macroglobulinemia) and some other B-cell lymphomas. They are not typically implicated in myeloid disorders or the described clinical syndrome.\n\nConsidering the combination of macrocytic anemia, relapsing polychondritis, and vacuolated precursors in myeloid and erythroid cells, UBA1 mutations leading to VEXAS syndrome are the most likely underlying genetic cause.\n\nThe answer is (B)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-003", "question": "A 45-year-old victim of a residential fire is intubated for airway protection. Due to suspected cyanide toxicity, a specific antidote is administered. Two hours later, the patient requires continuous renal replacement therapy (CRRT) for severe acidosis and acute kidney injury. Shortly after initiation, the CRRT machine repeatedly alarms and stops due to a 'Blood Leak' error, despite visual inspection of the effluent showing no frank blood. What is the mechanism of this technical complication?", "options": ["Hemolysis induced by the antidote", "Rhabdomyolysis myoglobin filtering", "Optical interference by the antidote", "Precipitation of antidote in the filter", "Coagulation of the filter membrane"], "answer": "C", "answer_index": 2, "explanation": "The patient received hydroxocobalamin (cyanokit), which has an intense red color. This chromophore passes into the ultrafiltrate/dialysate and is detected by the optical blood leak detector of the dialysis machine, causing a false-positive alarm that halts therapy. It also interferes with co-oximetry (falsely elevating HbCO) and colorimetric chemistry labs (creatinine, lactate) for days.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The question describes a scenario where a patient is receiving CRRT after suspected cyanide toxicity and antidote administration. The CRRT machine is alarming for a \"Blood Leak\" error despite no visible blood in the effluent. This suggests an issue with the optical sensor used to detect blood in the effluent.\n\nLet's analyze the options:\n\n*   **A. Hemolysis induced by the antidote:** While hemolysis can occur, it typically presents with visible red discoloration of the effluent, which is stated to be absent. Hemolysis itself wouldn't directly cause a \"blood leak\" alarm without visible blood.\n*   **B. Rhabdomyolysis myoglobin filtering:** Myoglobin is a protein released from damaged muscle. While it can cause AKI and be filtered, it's typically not the cause of a \"blood leak\" alarm unless it's in very high concentrations and causes turbidity that mimics blood to the optical sensor. However, the primary suspicion is related to the antidote.\n*   **C. Optical interference by the antidote:** Many antidotes, especially those used for cyanide toxicity (like hydroxocobalamin), are intensely colored. This color can interfere with the optical sensors in CRRT machines that are designed to detect the turbidity or color change associated with blood in the effluent. The sensor might interpret the color of the antidote as blood, triggering a false \"blood leak\" alarm.\n*   **D. Precipitation of antidote in the filter:** Precipitation of the antidote could potentially clog the filter, but it's less likely to directly cause a \"blood leak\" alarm unless the precipitate is so dense that it mimics blood to the optical sensor. However, optical interference is a more direct and common mechanism for this type of alarm with colored infusates.\n*   **E. Coagulation of the filter membrane:** Coagulation of the filter membrane would typically lead to decreased blood flow and potentially clotting within the circuit, but not necessarily a \"blood leak\" alarm unless the clotting is so severe that it causes micro-emboli that the sensor interprets as blood, or if the clotting leads to a breach in the membrane. However, the absence of frank blood makes this less likely than optical interference.\n\nConsidering the intense color of common cyanide antidotes like hydroxocobalamin, optical interference with the blood leak detector is the most plausible explanation for the alarm despite the absence of visible blood.\n\nThe final answer is $\\boxed{C}$."}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-004", "question": "A 3-week-old infant presents with a large, firm, violaceous, indurated plaque on the thigh that has rapidly expanded. Labs reveal profound thrombocytopenia (12,000/microL), hypofibrinogenemia, and elevated D-dimer. The attending physician diagnoses Kasabach-Merritt Phenomenon. Which of the following underlying vascular anomalies is most strongly associated with this complication?", "options": ["Infantile Hemangioma", "Kaposiform Hemangioendothelioma", "Venous Malformation", "Pyogenic Granuloma", "Port-wine Stain"], "answer": "B", "answer_index": 1, "explanation": "Kasabach-Merritt Phenomenon (KMP) is a life-threatening consumptive coagulopathy. Historically, it was incorrectly associated with common Infantile Hemangiomas. It is now known to be exclusively associated with rare, aggressive vascular tumors, specifically Kaposiform Hemangioendothelioma (KHE) and Tufted Angioma. Common infantile hemangiomas do *not* cause KMP.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The question describes Kasabach-Merritt Phenomenon (KMP), a rare but serious complication characterized by severe thrombocytopenia, hypofibrinogenemia, and elevated D-dimer, occurring in infants with certain vascular anomalies. The hallmark of KMP is the trapping of platelets and fibrinogen within the vascular tumor, leading to consumptive coagulopathy.\n\nLet's analyze the options:\n\nA. Infantile Hemangioma: While infantile hemangiomas are common vascular tumors in infants, they are less frequently associated with KMP compared to other lesions. When KMP does occur with infantile hemangiomas, it is usually with large, rapidly growing ones.\n\nB. Kaposiform Hemangioendothelioma (KHE): KHE is a rare vascular tumor that is strongly and most consistently associated with Kasabach-Merritt Phenomenon. The clinical presentation described (large, firm, violaceous, indurated plaque with rapid expansion) is highly suggestive of KHE.\n\nC. Venous Malformation: Venous malformations are typically present at birth and grow with the child. They are not typically associated with KMP.\n\nD. Pyogenic Granuloma: Pyogenic granulomas are acquired vascular lesions that grow rapidly and bleed easily. They are not associated with KMP.\n\nE. Port-wine Stain: Port-wine stains are congenital vascular malformations (capillary malformations) that are typically flat and pink to purple. They are not associated with KMP.\n\nGiven the strong association between Kaposiform Hemangioendothelioma and Kasabach-Merritt Phenomenon, and the clinical description provided, KHE is the most likely underlying vascular anomaly.\n\nThe answer is (B)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-005", "question": "A 58-year-old female presents with a 6-month history of progressive gait instability, dysarthria, and severe sleep dysfunction characterized by undifferentiated NREM/REM sleep and stridor. MRI brain is unremarkable. CSF analysis shows normal cell count and protein. Testing for which of the following antibodies is most likely to yield the diagnosis?", "options": ["Anti-Hu", "Anti-Yo", "Anti-IgLON5", "Anti-LGI1", "Anti-GABA-B"], "answer": "C", "answer_index": 2, "explanation": "Anti-IgLON5 disease is a distinct neurological syndrome characterized by a unique sleep disorder (parasomnias, sleep apnea, stridor) and bulbar dysfunction/gait instability. It is a tauopathy that bridges the gap between autoimmunity and neurodegeneration. The sleep architecture is often severely disorganized.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient presents with a constellation of neurological symptoms including progressive gait instability, dysarthria, and severe sleep dysfunction with undifferentiated NREM/REM sleep and stridor. The unremarkable MRI and normal CSF analysis point towards a paraneoplastic or autoimmune etiology that may not be readily apparent on standard imaging or CSF studies.\n\nLet's analyze the options:\n\nA. Anti-Hu antibodies are typically associated with paraneoplastic cerebellar degeneration, small cell lung cancer, and limbic encephalitis, often presenting with ataxia, dysarthria, and cognitive changes. While ataxia and dysarthria are present, the prominent sleep dysfunction is less characteristic.\n\nB. Anti-Yo antibodies are strongly associated with paraneoplastic cerebellar degeneration in women, usually linked to ovarian or breast cancer. The primary symptoms are subacute onset of severe ataxia and dysarthria. Sleep disturbances are not a hallmark.\n\nC. Anti-IgLON5 disease is a rare autoimmune disorder characterized by a unique combination of neurological symptoms including progressive gait instability, dysarthria, sleep disturbances (insomnia, hypersomnia, undifferentiated NREM/REM sleep, sleep-related breathing disorders like stridor), and often autonomic dysfunction. The patient's presentation aligns very well with the described features of anti-IgLON5 disease.\n\nD. Anti-LGI1 antibodies are associated with limbic encephalitis, often presenting with seizures, memory impairment, and psychiatric symptoms. While gait instability and dysarthria can occur, the prominent sleep dysfunction described is not a typical feature.\n\nE. Anti-GABA-B receptor antibodies are associated with limbic encephalitis, often presenting with seizures, memory impairment, and sometimes ataxia. Sleep disturbances are not a primary or defining feature.\n\nConsidering the patient's progressive gait instability, dysarthria, and particularly the severe sleep dysfunction with undifferentiated NREM/REM sleep and stridor, anti-IgLON5 disease is the most fitting diagnosis among the given options.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-006", "question": "A patient with severe chronic hyponatremia (Na 105 mEq/L) and concomitant hypokalemia (K 2.5 mEq/L) is admitted. The resident orders 40 mEq of IV KCl to correct the potassium. Two hours later, the serum sodium has risen to 112 mEq/L, exceeding the safe correction limit. What is the primary physiological mechanism for this rapid rise in serum sodium?", "options": ["Osmotic demyelination releasing sodium", "Intracellular sodium shift in exchange for potassium", "Aldosterone suppression", "Volume expansion suppression of ADH", "Renal sodium retention"], "answer": "B", "answer_index": 1, "explanation": "Administered potassium enters cells to replenish intracellular stores; to maintain electroneutrality, sodium exits the cells into the extracellular space. Therefore, potassium administration acts osmotically equivalent to sodium administration in raising serum tonicity. Additionally, correcting hypokalemia may improve renal concentrating ability, but the cation exchange is the immediate cause of the rapid sodium rise.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient has severe hyponatremia and hypokalemia. The administration of IV KCl is intended to correct the potassium deficiency.\n\nLet's analyze the options:\n\nA. Osmotic demyelination is a neurological complication that can occur with rapid correction of hyponatremia, but it is a consequence, not a mechanism for the sodium rise itself.\n\nB. Intracellular sodium shift in exchange for potassium is a plausible mechanism. When extracellular potassium is low (hypokalemia), potassium tends to shift out of cells to try and normalize the extracellular concentration. This shift can be accompanied by a reciprocal shift of sodium into the cells to maintain electrical neutrality. Conversely, when extracellular potassium is administered and rises, potassium shifts back into the cells. This movement of potassium into cells can drive sodium out of cells and back into the extracellular space, thereby increasing serum sodium concentration.\n\nC. Aldosterone suppression would lead to decreased sodium reabsorption and increased potassium excretion, which would worsen hyponatremia, not cause a rapid rise.\n\nD. Volume expansion suppression of ADH is a mechanism that can occur with fluid administration, leading to increased free water excretion and a rise in sodium. However, the primary intervention here is KCl administration, not necessarily volume expansion. While some IV fluids might be used, the question focuses on the effect of KCl.\n\nE. Renal sodium retention would lead to an increase in serum sodium, but the rapid rise observed (7 mEq/L in 2 hours) suggests a more immediate physiological shift rather than a slower process of renal retention.\n\nConsidering the severe hypokalemia and the administration of potassium, the most direct and rapid physiological mechanism for the serum sodium to rise is the shift of sodium out of cells as potassium enters.\n\nThe final answer is $\\boxed{B}$."}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-007", "question": "A 14-year-old male presents with delayed umbilical stump bleeding as a neonate and now has a history of poor wound healing and recurrent soft tissue hematomas. Standard coagulation screening tests (PT, aPTT, fibrinogen, platelet count) are all consistently normal. A urea solubility test is performed and shows clot dissolution. Which factor deficiency is the diagnosis?", "options": ["Factor VIII", "Factor IX", "Factor XI", "Factor XIII", "Alpha-2-antiplasmin"], "answer": "D", "answer_index": 3, "explanation": "Factor XIII (Fibrin Stabilizing Factor) is responsible for cross-linking fibrin monomers. Deficiency leads to unstable clots that dissolve in 5M urea (or monochloroacetic acid). Because the coagulation cascade up to the formation of the fibrin polymer is intact, the standard PT and aPTT are normal. The clinical hallmark is delayed bleeding (e.g., umbilical stump) and poor wound healing.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "D", "model_outputs": "The patient presents with a history suggestive of a bleeding disorder, specifically delayed umbilical stump bleeding, poor wound healing, and recurrent soft tissue hematomas. Standard coagulation screening tests (PT, aPTT, fibrinogen, platelet count) are normal, which helps to rule out common deficiencies in the extrinsic, intrinsic, and common pathways of coagulation, as well as platelet dysfunction.\n\nThe key finding is the urea solubility test showing clot dissolution. This test is specifically designed to assess the stability of a fibrin clot. A normal clot is insoluble in urea, meaning it remains intact. If the clot dissolves in urea, it indicates a deficiency in Factor XIII, also known as fibrin-stabilizing factor. Factor XIII is essential for cross-linking fibrin monomers, which strengthens and stabilizes the fibrin clot, making it resistant to lysis.\n\nLet's consider the options:\nA. Factor VIII deficiency (Hemophilia A) typically presents with bleeding into joints and muscles, and prolonged aPTT.\nB. Factor IX deficiency (Hemophilia B) also presents with similar bleeding symptoms to Hemophilia A, and prolonged aPTT.\nC. Factor XI deficiency (Hemophilia C) can cause bleeding, but it's often less severe than Hemophilia A or B, and can manifest as post-operative or post-traumatic bleeding. PT and aPTT may be normal or mildly prolonged.\nD. Factor XIII deficiency is characterized by a tendency for bleeding that is often delayed, poor wound healing, recurrent hematomas, and umbilical stump bleeding. The hallmark laboratory finding is a clot that dissolves in urea or 5M urea.\nE. Alpha-2-antiplasmin is a component of the fibrinolytic system, and its deficiency would lead to excessive fibrinolysis and bleeding. However, the urea solubility test is not directly used to diagnose alpha-2-antiplasmin deficiency.\n\nGiven the clinical presentation and the positive urea solubility test, Factor XIII deficiency is the most likely diagnosis.\n\nThe answer is (D)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-008", "question": "A 22-year-old male is brought to the ED after ingesting a rodenticide. He is alert but complains of extreme weakness. Examination reveals generalized flaccid paralysis. ECG shows premature ventricular complexes. Labs show a serum potassium of 1.8 mEq/L. Which toxin is most likely responsible, and what is the mechanism?", "options": ["Arsenic; uncoupling of oxidative phosphorylation", "Thallium; substitution for potassium in ATPase", "Barium; blockade of potassium efflux channels", "Strychnine; glycine receptor antagonism", "Sodium monofluoroacetate; aconitase inhibition"], "answer": "C", "answer_index": 2, "explanation": "Barium carbonate (found in certain rodenticides and ceramics) causes profound hypokalemia by blocking the inward rectifier potassium channels (Kir), preventing potassium efflux from cells, while the Na-K-ATPase continues to pump potassium in. This results in severe intracellular shift of potassium, leading to paralysis and arrhythmias. Treatment requires aggressive potassium replacement.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient presents with symptoms suggestive of severe hypokalemia (serum potassium 1.8 mEq/L) including generalized flaccid paralysis and premature ventricular complexes. The history of rodenticide ingestion points to a toxic exposure. Let's analyze the options:\n\nA. Arsenic poisoning can cause neurological symptoms and gastrointestinal distress, but hypokalemia is not a primary or consistent feature. Uncoupling of oxidative phosphorylation is a known mechanism of arsenic toxicity.\n\nB. Thallium poisoning is known to cause a constellation of symptoms including alopecia, gastrointestinal distress, and neurological deficits. Crucially, thallium is chemically similar to potassium and can substitute for it in various cellular processes, including ATPase pumps, leading to hypokalemia and paralysis.\n\nC. Barium poisoning can cause hypokalemia and paralysis by blocking potassium efflux channels, leading to intracellular accumulation of potassium and reduced extracellular potassium. However, thallium's mechanism of substituting for potassium is a more direct explanation for severe hypokalemia in the context of rodenticide ingestion.\n\nD. Strychnine poisoning is characterized by severe muscle spasms, hyperreflexia, and seizures due to glycine receptor antagonism. This is the opposite of the flaccid paralysis seen in the patient.\n\nE. Sodium monofluoroacetate is a potent rodenticide that is metabolized to fluorocitrate, which inhibits aconitase, a key enzyme in the Krebs cycle. This leads to citrate accumulation and energy depletion. While it can cause neurological symptoms, severe hypokalemia is not its hallmark.\n\nConsidering the severe hypokalemia and flaccid paralysis in a patient who ingested rodenticide, thallium poisoning is the most likely culprit due to its ability to substitute for potassium in cellular processes, leading to profound hypokalemia.\n\nThe answer is (B)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-009", "question": "A 2-year-old boy presents with failure to thrive and chronic steatorrhea. Examination reveals absent deep tendon reflexes and ataxia. A peripheral blood smear demonstrates numerous acanthocytes. A lipid panel shows extremely low levels of cholesterol and triglycerides, and absent LDL. Which of the following is the primary pathophysiology?", "options": ["Defect in the LDL receptor", "Mutation in the ABCA1 gene", "Microsomal triglyceride transfer protein (MTP) deficiency", "Lipoprotein lipase deficiency", "Apolipoprotein C-II deficiency"], "answer": "C", "answer_index": 2, "explanation": "This is Abetalipoproteinemia (Bassen-Kornzweig syndrome). It is caused by a mutation in the MTP gene, which is required for the assembly and secretion of apoB-containing lipoproteins (Chylomicrons, VLDL, LDL). The absence of these lipoproteins leads to fat malabsorption (steatorrhea), vitamin E deficiency (spinocerebellar degeneration, absent DTRs), and lipid membrane defects (acanthocytosis).", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient presents with a constellation of symptoms highly suggestive of abetalipoproteinemia. Let's analyze the findings:\n\n*   **Failure to thrive and chronic steatorrhea:** This indicates malabsorption of fats, which is a hallmark of conditions affecting lipid absorption and transport.\n*   **Absent deep tendon reflexes and ataxia:** These are neurological symptoms often seen in vitamin E deficiency, which can occur secondary to fat malabsorption. Vitamin E is a fat-soluble vitamin.\n*   **Numerous acanthocytes:** These are red blood cells with spiky projections, a characteristic finding in abetalipoproteinemia due to abnormal lipid composition of the red blood cell membrane.\n*   **Extremely low levels of cholesterol and triglycerides, and absent LDL:** This is the most definitive clue. LDL (low-density lipoprotein) is the primary carrier of cholesterol in the blood. Its absence, along with very low triglycerides, points to a severe defect in the assembly and secretion of apoB-containing lipoproteins (chylomicrons, VLDL, and LDL).\n\nNow let's consider the options:\n\n*   **A. Defect in the LDL receptor:** This would lead to familial hypercholesterolemia, characterized by *high* LDL levels, not absent LDL.\n*   **B. Mutation in the ABCA1 gene:** Mutations in ABCA1 are associated with Tangier disease, which involves impaired cholesterol efflux from cells and leads to low HDL levels, but typically not absent LDL or severe fat malabsorption.\n*   **C. Microsomal triglyceride transfer protein (MTP) deficiency:** MTP is essential for the assembly and secretion of apoB-containing lipoproteins, including chylomicrons and VLDL. Deficiency of MTP leads to the inability to package triglycerides and cholesterol into these lipoproteins, resulting in absent LDL, very low triglycerides, fat malabsorption, and neurological symptoms due to vitamin deficiencies. This perfectly matches the patient's presentation.\n*   **D. Lipoprotein lipase deficiency:** Lipoprotein lipase (LPL) is responsible for hydrolyzing triglycerides in chylomicrons and VLDL. LPL deficiency leads to *high* triglyceride levels (hypertriglyceridemia) and the presence of chylomicrons, not absent LDL and low triglycerides.\n*   **E. Apolipoprotein C-II deficiency:** ApoC-II is a cofactor for LPL. Its deficiency impairs LPL activity, leading to high triglyceride levels, similar to LPL deficiency.\n\nTherefore, MTP deficiency is the primary pathophysiology that explains all the observed clinical and laboratory findings.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-010", "question": "A 40-year-old male with a history of migraine with aura presents with cognitive decline and a recent lacunar stroke. He has no hypertension or vascular risk factors. MRI of the brain reveals extensive white matter hyperintensities, specifically involving the anterior temporal poles and external capsules. Genetic testing would likely reveal a mutation in which gene?", "options": ["NOTCH3", "GLA", "HTRA1", "APP", "COL4A1"], "answer": "A", "answer_index": 0, "explanation": "This is the classic presentation of CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy). The mutation is in the *NOTCH3* gene. The MRI finding of hyperintensities in the anterior temporal poles is highly sensitive and specific for CADASIL, distinguishing it from chronic hypertensive microangiopathy.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The patient's presentation of migraine with aura, cognitive decline, lacunar stroke, and extensive white matter hyperintensities, particularly in the anterior temporal poles and external capsules, in the absence of typical vascular risk factors, is highly suggestive of Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL).\n\nCADASIL is a genetic disorder caused by mutations in the NOTCH3 gene. The NOTCH3 protein is involved in the development and maintenance of blood vessels, and mutations in this gene lead to a buildup of granular osmiophilic material in the walls of small arteries and arterioles, causing them to thicken and become dysfunctional. This dysfunction can lead to microinfarcts, white matter lesions, and ultimately cognitive decline and stroke.\n\nLet's consider why the other options are less likely:\n\nB. GLA: Mutations in the GLA gene cause Fabry disease, a lysosomal storage disorder that can affect the nervous system, but the typical presentation and MRI findings are different from what is described.\n\nC. HTRA1: Mutations in the HTRA1 gene are associated with diseases like Hereditary Vascular Dementia and CADASIL-like syndromes, but NOTCH3 is the primary gene associated with classic CADASIL. While there can be overlap in phenotypes, NOTCH3 is the most direct and common cause of the described constellation of symptoms.\n\nD. APP: Mutations in the APP gene are associated with early-onset Alzheimer's disease, which typically presents with memory loss as the predominant symptom and different patterns of brain involvement on MRI.\n\nE. COL4A1: Mutations in COL4A1 gene are associated with various vascular disorders, including cerebral microbleeds and stroke, but the specific pattern of white matter hyperintensities and the strong association with migraine with aura point more strongly towards CADASIL.\n\nTherefore, the most likely gene mutation in this patient is in NOTCH3.\n\nThe answer is (A)"}]